Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies

BACKGROUND: Fremanezumab, a fully humanized monoclonal antibody that selectively targets calcitonin gene-related peptide, has demonstrated efficacy for preventive treatment of episodic and chronic migraine. Since calcitonin gene-related peptide is expressed within the cardio- and cerebrovascular sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Diener, Hans Christoph, McAllister, Peter, Jürgens, Tim P, Kessler, Yoel, Ning, Xiaoping, Cohen, Joshua M, Campos, Verena Ramirez, Barash, Steve, Silberstein, Stephen D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218411/
https://www.ncbi.nlm.nih.gov/pubmed/35331009
http://dx.doi.org/10.1177/03331024221076485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218411/
https://www.ncbi.nlm.nih.gov/pubmed/35331009
http://dx.doi.org/10.1177/03331024221076485

Ejemplares similares